Mazokalim
Alternative Names: UK 143220Latest Information Update: 23 Jul 2002
At a glance
- Originator Pfizer
- Class Antihypertensives; Benzopyrans; Muscle relaxants; Small molecules
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Hypertension
Most Recent Events
- 27 Sep 2000 Pfizer has licensed the electrohydrodynamic pulmonary delivery technology of Battelle Pulmonary Therapeutics
- 23 Jun 2000 Pfizer has merged with Warner-Lambert
- 21 Mar 2000 Profile reviewed but no significant changes made